{
    "nctId": "NCT02384733",
    "briefTitle": "Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost",
    "officialTitle": "The Skagen Trial 1, Moderately Hypofractionated Loco-regional Adjuvant Radiation Therapy of Early Breast Cancer Combined With a Simultaneous Integrated Boost: a Randomised Clinically Controlled Trial",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Lymphedema, Fibrosis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 2963,
    "primaryOutcomeMeasure": "Development of ipsilateral arm lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\nOperated for early node-positive breast cancer with indication for loco-regional breast radiotherapy\n\nExclusion Criteria:\n\nPrevious radiotherapy to chest wall, pregnant/lactating, comorbidity which may hinder 10 years follow up",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}